BusinessEmerald Health Pharmaceuticals to Treat Life-Threatening Diseases with Novel Synthetic Cannabinoid-Derived MoleculesBy Nasdaq OMXSep 14, 2017, 1:00 PM UTC
BusinessCURE Pharmaceutical Launches New Academic Partnership Program Providing the Company’s Proprietary CureFilm™ for More Humane and Effective Animal ResearchBy Nasdaq OMXSep 6, 2017, 1:00 PM UTC
BusinessCURE Pharmaceutical Subsidiary, Oak Therapeutics, Completes Critical Milestone in Phase 1 of NIH Grant to Develop Oral Dissolvable Strip for TuberculosisBy Nasdaq OMXAug 22, 2017, 3:19 PM UTC
BusinessCURE Pharmaceutical Expects Increased Demand for Its Enhanced Transdermal Drug Delivery PlatformBy Nasdaq OMXJul 5, 2017, 1:00 PM UTC
BusinessComprehensive Study by AstraZeneca and Genentech Confirms Superiority of InSphero Human Liver Microtissues for Prediction of Drug-Induced Liver InjuryBy Nasdaq OMXJun 29, 2017, 12:00 PM UTC
BusinessCURE Pharmaceutical Appoints CannaKids CEO and Cannabis Cancer Advocate Tracy Ryan to Advisory BoardBy Nasdaq OMXJun 27, 2017, 1:00 PM UTC
BusinessLeading OTF Manufacturer CURE Pharmaceutical Comments on New Report Showing Exponential Growth in Thin Film Drug Manufacturing MarketBy Nasdaq OMXJun 7, 2017, 3:14 PM UTC
BusinessAtlant Clinical to host first MedDRA Face-to-Face Trainings in RussiaBy Nasdaq OMXMay 31, 2017, 4:51 PM UTC
